In real-world settings there is an array of factors that may contribute to non-persistence, including medication supply shortages, adverse effects, high out-of-pocket costs and real-world weight reduction not meeting the patients expectations.
Obesity: Total Disruption and the Collapse of the Old Hierarchy Level of disruption: Total With sustained weight loss approaching 2530%, retatrutide crosses a historic threshold: pharmacology enters territory previously reserved for bariatric surgery
Trial exclusion patterns Phase 2 and Phase 3 retatrutide trials commonly excluded participants with a history of pancreatitis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), severe gastroparesis, recent major cardiovascular events, severe kidney impairment, type 1 diabetes (in the obesity studies), and pregnancy or breastfeeding
Peptides are short chains of amino acids that signal the body to repair, heal, burn fat, build collagen, or improve hormonal function
These medications can: Change appetite signaling and food intake patterns Affect hydration and micronutrient intake Worsen certain GI conditions Influence muscle and bone mass during weight loss Interact with other medications and health conditions Informed care means: Screening for contraindications and risks Considering mental health and eating disorder history Discussing reproductive goals and contraception Planning nutrition and strength support from the start Reassessing regularly, not set-and-forget prescribing Trying something powerful without a plan is not neutral. The Bottom Line GLP-1 medications can be a great fit for some people and a poor fit for others
doi: 10.1152/ajpregu.00588.2012 14 SandovalD